The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research
Open accessAbstract
The lack of readily available biomarkers is a significant hindrance toward progressing to effective therapeutic and preventative strategies for Alzheimer's disease (AD). Blood‐based biomarkers have potential to overcome access and cost barriers and greatly facilitate advanced neuroimaging and cerebrospinal fluid biomarker approaches. Despite the fact that preanalytical processing is the largest source of variability in laboratory testing, there are no currently available standardized preanalytical guidelines. The current international working group provides the initial starting point for such guidelines for standardized operating procedures (SOPs). It is anticipated that these guidelines will be updated as additional research findings become available. The statement provides (1) a synopsis of selected preanalytical methods utilized in many international AD cohort studies, (2) initial draft guidelines/SOPs for preanalytical methods, and (3) a list of required methodological information and protocols to be made available for publications in the field to foster cross‐validation across cohorts and laboratories.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702 · cited 1×
“While there are a large number of factors contributing to this issue, one key factor is the substantial variability in study designs, definitions, outcomes, and analytic models that make replication less likely [1].”
BackgroundHearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Believe it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888 · cited 1×
“In fact, an “unspoken rule” among venture capital firms is that 50% of published studies will not replicate in industrial labs [4] and the National Institutes of Health (NIH) recently outlined a plan to address this problem [2].”
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Self-citationHansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Self-citationMonetary Costs of Dementia in the United States
Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1204629 · Cited by 1,484
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Self-citationPolicy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 2×
“distinguishedADpatients from healthy controlswith an overall classification accuracy of 89% and accurately identified 81% of mild cognitive impairment (MCI) patients who progressed to AD within a 2- to 6-year follow-up period [18].”
Self-citationAlzheimer’s Dementia: Dilemmas in Clinical Research
(1985) · Humana Press eBooks · doi:10.1007/978-1-4612-5174-3 · Cited by 981
Ellis, K. A., Bush, A. I., Darby, D., De Fazio, D., Foster, J., Hudson, P., Lautenschlager, N. T., Lenzo, N., Martins, R. N., Maruff, P., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 968
Self-citationTietz Fundamentals of Clinical Chemistry
Burtis, E. B. C. A., & Ashwood, E. R. (1996) · Cited by 919
Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.noc60123 · Cited by 897 · cited 1×
“Louis, and two of these analytes were found to be highly correlated with the CSF t-tau/Aβ42 ratio[30], a strong predictor of future cognitive decline [32,33].”
BackgroundSelf-citationBonini, P., Plebani, M., Ceriotti, F., & Rubboli, F. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.5.691 · Cited by 850
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
(1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 666
Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
Mistakes in a stat laboratory: types and frequency
Plebani, M., & Carraro, P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1348 · Cited by 572
Rai, A. J., Gelfand, C. A., Haywood, B. C., Warunek, D. J., Yi, J., Schuchard, M. D., Mehigh, R. J., Cockrill, S. L., Scott, G. B. I., Tammen, H., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401245 · Cited by 545
Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories
Lippi, G., Blanckaert, N., Bonini, P., Green, S., Kitchen, S., Palicka, V., Vassault, A. J., & Plebani, M. (2008) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2008.170 · Cited by 466
Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
Doecke, J. D. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1282 · Cited by 421
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Mattsson, N., Andreasson, U., Persson, S., Arai, H., Batish, S. D., Bernardini, S., Bocchio‐Chiavetto, L., Blankenstein, M. A., Carrillo, M. C., Chalbot, S., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2243 · Cited by 413
Self-citationCSF biomarker variability in the Alzheimer's Association quality control program
Mattsson, N., Andreasson, U., Persson, S., Carrillo, M. C., Collins, S., Chalbot, S., Cutler, N., Dufour‐Rainfray, D., Fagan, A. M., Heegaard, N. H. H., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.010 · Cited by 382
Self-citationIssaq, H. J., Xiao, Z., & Veenstra, T. D. (2007) · Chemical Reviews · doi:10.1021/cr068287r · Cited by 315
The future of blood‐based biomarkers for Alzheimer's disease
Henriksen, K., O'Bryant, S. E., Hampel, H., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.013 · Cited by 313
Self-citationStability studies of twenty-four analytes in human plasma and serum
Boyanton, B. L., & Blick, K. E. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.12.2242 · Cited by 309
Clinical proteomics: A need to define the field and to begin to set adequate standards
Mischak, H., Apweiler, R., Banks, R. E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J. H. H., Fliser, D., Girolami, M., Hermjakob, H., et al. (2007) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200600771 · Cited by 307
Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
Vanderstichele, H., Kerschaver, E. V., Hesse, C., Davidsson, P., Buyse, M.-A., Andreasen, N., Minthon, L., Wallin, A., Blennow, K., & Vanmechelen, E. (2000) · Amyloid · doi:10.3109/13506120009146438 · Cited by 301
Self-citationNACB Writing Group Members, Apple, F. S., Jesse, R. L., Newby, L. K., Wu, A. H. B., & Christenson, R. H. (2007) · Circulation · doi:10.1161/circulationaha.107.182881 · Cited by 300
Atherosclerosis and AD: Analysis of data from the US National Alzheimer’s Coordinating Center
Honig, L. S., Kukull, W., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000150886.50187.30 · Cited by 284
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
Hu, W. T., Holtzman, D. M., Fagan, A. M., Shaw, L. M., Perrin, R., Arnold, S. E., Grossman, M., Xiong, C., Craig-Schapiro, R., Clark, C. M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318266fa70 · Cited by 241
Self-citationImpact of blood collection devices on clinical chemistry assays
Bowen, R. A. R., Hortin, G. L., Csako, G., Otañez, O. H., & Remaley, A. T. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.10.001 · Cited by 240
Preanalytical quality improvement: in quality we trust
Lippi, G., Becan-McBride, K., Behúlová, D., Bowen, R. A., Church, S., Delanghe, J., Grankvist, K., Kitchen, S., Nybo, M., Nauck, M., et al. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0597 · Cited by 236
The Role of Biomarkers in Clinical Trials for Alzheimer Disease
Thal, L. J., Kantarci, K., Reiman, E. M., Klunk, W. E., Weiner, M. W., Zetterberg, H., Galasko, D., Praticò, D., Griffin, S., Schenk, D., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000191420.61260.a8 · Cited by 232
Self-citationA Serum Protein–Based Algorithm for the Detection of Alzheimer Disease
O’Bryant, S. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.215 · Cited by 230
Self-citationMorris, J. C., Aisen, P. S., Bateman, R. J., Benzinger, T. L., Cairns, N. J., Fagan, A. M., Ghetti, B., Goate, A. M., Holtzman, D. M., Klunk, W. E., et al. (2012) · Clinical Investigation · doi:10.4155/cli.12.93 · Cited by 208
Self-citationReddy, M. M., Wilson, R., Wilson, J., Connell, S., Gocke, A., Hynan, L., German, D., & Kodadek, T. (2011) · Cell · doi:10.1016/j.cell.2010.11.054 · Cited by 203
Kiddle, S. J., Sattlecker, M., Proitsi, P., Simmons, A., Westman, E., Bazenet, C., Nelson, S. K., Williams, S., Hodges, A., Johnston, C., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130380 · Cited by 189
Self-citationDeveloping novel blood‐based biomarkers for Alzheimer's disease
Snyder, H. M., Carrillo, M. C., Grodstein, F., Henriksen, K., Jeromin, A., Lovestone, S., Mielke, M. M., O'Bryant, S., Sarasa, M., Sj⊘gren, M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.007 · Cited by 177
Self-citationDiagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Han, M., Nagele, E., DeMarshall, C., Acharya, N., & Nagele, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032383 · Cited by 176
Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
Schneider, P., Hampel, H. J., & Büerger, K. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00104.x · Cited by 165
Self-citationDiagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Nagele, E. P., Han, M. C., DeMarshall, C. A., Belinka, B. A., & Nagele, R. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023112 · Cited by 164
Lewczuk, P., Beck, G., Esselmann, H., Bruckmoser, R., Zimmermann, R., Fiszer, M., Bibl, M., Maler, J. M., Kornhuber, J., & Wiltfang, J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.058776 · Cited by 162
Biomarkers in Alzheimer's disease drug development
Blennow, K. (2010) · Nature Medicine · doi:10.1038/nm.2221 · Cited by 162
Self-citationO'Bryant, S. E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., Edwards, M., Graff-Radford, N., Doody, R., Diaz-Arrastia, R., for the Texas Alzheimer's Research & Care Consortium, et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028092 · Cited by 158
Self-citationBlood and plasma-based proteomic biomarker research in Alzheimer's disease
Lista, S., Faltraco, F., Prvulovic, D., & Hampel, H. J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.007 · Cited by 145
Self-citationRai, A. J., & Vitzthum, F. (2006) · Expert Review of Proteomics · doi:10.1586/14789450.3.4.409 · Cited by 138
Biobanking in microbiology: From sample collection to epidemiology, diagnosis and research
Paoli, P. D. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.01.005 · Cited by 135
Carrillo, M. C., Blennow, K., Soares, H. D., Lewczuk, P., Mattsson, N., Oberoi, P., Umek, R. M., Vandijck, M. L. J., Salamone, S. J., Bittner, T., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.003 · Cited by 133
Self-citationSoares, H. D., Chen, Y., Sabbagh, M. N., Rohrer, A., Schrijvers, E. M. C., & Breteler, M. M. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05066.x · Cited by 121
Self-citationKennedy, C., Angermuller, S., King, R., Noviello, S., Walker, J., Warden, J., & Vang, S. (1996) · Journal of Emergency Nursing · doi:10.1016/s0099-1767(96)80213-3 · Cited by 115
Scaling of Hemolysis in Needles and Catheters
Sharp, M. K., & Mohammad, S. (1998) · Annals of Biomedical Engineering · doi:10.1114/1.65 · Cited by 114
A Gene Expression Pattern in Blood for the Early Detection of Alzheimer's Disease
Booij, B. B., Lindahl, T., Wetterberg, P., Skaane, N. V., Sæbø, S., Feten, G., Rye, P. D., Kristiansen, L., Hagen, N., Jensen, M., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101518 · Cited by 114
Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes
Perret‐Liaudet, A., Pelpel, M., Tholance, Y., Dumont, B., Vanderstichele, H., Zorzi, W., Elmoualij, B., Schraen‐Maschke, S., Moreaud, O., Gabelle, A., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120361 · Cited by 109
A Blood-Based Algorithm for the Detection of Alzheimer’s Disease
O’Bryant, S. E., Xiao, G., Barber, R. C., Reisch, J., Hall, J. R., Cullum, C. M., Doody, R. S., Fairchild, T., Adams, P. M., Wilhelmsen, K. C., et al. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330750 · Cited by 104
Self-citationDugan, L., Leech, L., Speroni, K., & Corriher, J. (2005) · Journal of Emergency Nursing · doi:10.1016/j.jen.2005.05.004 · Cited by 103
Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
Blennow, K., Hampel, H. J., & Zetterberg, H. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.154 · Cited by 87
Self-citationStorage of whole blood: effect of temperature on the measured concentration of analytes in serum.
Rehak, N. N., & Chiang, B. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.10.2111 · Cited by 76
The use of SELDI-TOF MS in the search for biological markers of Alzheimer’s disease
Watt, A. D. (2013) · Minerva Access (University of Melbourne) · Cited by 75
Identification of a blood-based biomarker panel for classification of Alzheimer's disease
Laske, C., Leyhe, T., Stransky, E., Hoffmann, N. A., Fallgatter, A. J., & Dietzsch, J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000459 · Cited by 72
Self-citationBiomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
Galasko, D. R., & Golde, T. E. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt164 · Cited by 66
Biological and methodical challenges of blood-based proteomics in the field of neurological research
Lista, S., Faltraco, F., & Hampel, H. J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.006 · Cited by 61
Self-citationElevated Serum Potassium Values
Stanković, A. K., & Smith, S. (2004) · Pathology Patterns Reviews · doi:10.1309/uepqum11wh9p8jny · Cited by 61
Protein instability following transport or storage on dry ice
Murphy, B. M., Swarts, S., Mueller, B. M., van der Geer, P., Manning, M. C., & Fitchmun, M. I. (2013) · Nature Methods · doi:10.1038/nmeth.2409 · Cited by 58
Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease Diagnosis
Perret‐Liaudet, A., Pelpel, M., Tholance, Y., Dumont, B., Vanderstichele, H., Zorzi, W., Elmoualij, B., Schraen‐Maschke, S., Moreaud, O., Gabelle, A., et al. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.178368 · Cited by 58
Impact of preanalytical variables on the analysis of biological fluids in proteomic studies
Ferguson, R. E., Hochstrasser, D. F., & Banks, R. E. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700380 · Cited by 55
Antecedent Biomarkers of Alzheimer’s Disease: The Adult Children Study
Coats, M., & Morris, J. C. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281881 · Cited by 44
Variability in Blood-Based Amyloid-β Assays: The Need for Consensus on Pre-Analytical Processing
Watt, A. D., Perez, K. A., Rembach, A., Masters, C. L., Villemagne, V. L., & Barnham, K. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120058 · Cited by 43
Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20
Pica-Mendez, A. M., Tanen, M., Dallob, A. L., Tanaka, W. K., & Laterza, O. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.019 · Cited by 43
The clinical chemistry laboratory: current status, problems and diagnostic prospects
Schleicher, E. D. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-0185-4 · Cited by 43
Büerger, K., Ernst, A. S., Ewers, M., Uspenskaya, O., Omerovic, M., Morgenthaler, N. G., Knauer, K., Bergmann, A., & Hampel, H. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.032 · Cited by 41
Self-citationPetersen, R. C., & Trojanowski, J. Q. (2009) · JAMA · doi:10.1001/jama.2009.1073 · Cited by 40
Self-citationEvaluation and Use of Diagnostic Tests in Alzheimer’s Disease
Mayeux, R. P. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00014-1 · Cited by 39
Boone, D. J., Steindel, S. D., Herron, R., Howanitz, P. J., Bachner, P., Meier, F. A. D. E., Schifman, R. B., & Zarbo, R. B. (1995) · PubMed · Cited by 36
Lachno, D. R., Vanderstichele, H., Groote, G. D., Kostanjevečki, V., Meyer, G. D., Siemers, E., Willey, M. B., Bourdage, J. S., Konrad, R. J., & Dean, R. A. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0062-5 · Cited by 34
Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement
Hampel, H. J., & Lista, S. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0003-1 · Cited by 29
Self-citationLaboratory sampling. Does the process affect the outcome?
Becan-McBride, K. (2000) · PubMed · Cited by 28
Wipfler, P., Heikkinen, A., Harrer, A., Pilz, G., Kunz, A. B., Golaszewski, S. M., Reuß, R., Oschmann, P., & Kraus, J. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6622-3 · Cited by 26
Laske, C., Schmohl, M., Leyhe, T., Stransky, E., Maetzler, W., Berg, D., Fallgatter, A. J., Joos, T. O., & Dietzsch, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121558 · Cited by 25
Self-citationMapping Out Biomarkers for Alzheimer Disease
Breteler, M. M. B. (2011) · JAMA · doi:10.1001/jama.2010.2017 · Cited by 24
Self-citationProgress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
Rembach, A., Ryan, T. M., Roberts, B. R., Doecke, J. D., Wilson, W. J., Watt, A. D., Barnham, K. J., & Masters, C. L. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.59 · Cited by 20
Using blood markers for Alzheimer disease in clinical practice?
O’Bryant, S. E. (2012) · Neurology · doi:10.1212/wnl.0b013e318266fd21 · Cited by 8
Self-citationA risk-analysis approach to the evaluation of analytical quality
Ceriotti, F., Cappelletti, P., Caputo, M., Serio, F. D., Messeri, G., Ottomano, C., Plebani, M., & Soffiati, G. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.740 · Cited by 8
Cited by
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Self-citationPreclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citationHigh performance plasma amyloid-β biomarkers for Alzheimer's disease
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Doré, V., Fowler, C., Li, Q.-X., Martins, R., Rowe, C., et al. (2018) · Nature · doi:10.1038/nature25456 · Cited by 1,681
Self-citationBiomarkers for Alzheimer's disease: current status and prospects for the future
Blennow, K., & Zetterberg, H. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12816 · Cited by 1,000
Self-citationBlood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Hampel, H., O’Bryant, S. E., Molinuevo, J. L., Zetterberg, H., Masters, C. L., Lista, S., Kiddle, S. J., Batrla, R., & Blennow, K. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0079-7 · Cited by 716
Self-citation
Metadata
- Authors
- O'Bryant, S. E., Gupta, V., Henriksen, K., Edwards, M., Jeromin, A., Lista, S., Bazenet, C., Soares, H., Lovestone, S., Hampel, H., Montine, T., Blennow, K., Foroud, T., Carrillo, M., Graff-Radford, N., Laske, C., Breteler, M., Shaw, L., Trojanowski, J. Q., Schupf, N., Rissman, R. A., Fagan, A. M., Oberoi, P., Umek, R., Weiner, M. W., Grammas, P., Posner, H., Martins, R., & groups, S.-B. A. B. W.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2014-09-30
- Volume
- 11
- Issue
- 5
- Pages
- 549-560
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2115866516
- Cited by
- 290
- References
- 85
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.